A large study into rare blood clots linked with AstraZeneca’s COVID-19 vaccine found between just one and three cases per million, and only after the first dose, shedding fresh light…
New Delhi, Feb 19 (PTI) Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech’s…
NAGPUR: The drive for 15+ years group remained affected on Friday at many centres as doses were received late on Wednesday evening and sessions couldn’t be planned in schools and…
India could soon have its first messenger or mRNA vaccine soon, with the near-completion of Phase 3 clinical trials by Gennova Biopharmaceuticals, even as the company also started developing a…
Vaccine major Serum Institute of India (SII) on Tuesday said the approval for the COVID-19 vaccine ‘Covovax’ would strengthen immunization initiatives across India and various lower and middle income countries…
Moderna Inc said on Monday that a booster dose of its COVID-19 vaccine appeared to be protective against the fast-spreading Omicron variant in laboratory testing and that the current version…
NEW DELHI: Indian Covid-19 vaccine makers are lobbying the government to authorise boosters as supplies have so outstripped demand that one drugmaker told Reuters it had suspended a plan to…
The issue of administering ‘additional’ dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon in the meeting of the National Technical Advisory Group on Immunisation scheduled to be…
NEW DELHI: A parliamentary panel looking into the Covid-19 outbreak and management has asked the government to expeditiously evaluate the efficacy of vaccine against the Omicron strain, whose spread has…
NEW DELHI: Myanmar, Bangladesh, Nepal and Iran have been the first recipients of resumed vaccine exports from India almost eight months after they were halted due to rising cases of…
